Shikiar Asset Management’s Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock FBIOP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-15,000
| Closed | -$262K | – | 78 |
|
2023
Q2 | $262K | Sell |
15,000
-37,500
| -71% | -$655K | 0.08% | 65 |
|
2023
Q1 | $966K | Buy |
+52,500
| New | +$966K | 0.34% | 42 |
|
2022
Q3 | $1.16M | Sell |
62,000
-13,000
| -17% | -$244K | 0.47% | 40 |
|
2022
Q2 | $1.37M | Sell |
75,000
-20,460
| -21% | -$373K | 0.53% | 36 |
|
2022
Q1 | $2.29M | Sell |
95,460
-23,800
| -20% | -$571K | 0.65% | 33 |
|
2021
Q4 | $3.09M | Sell |
119,260
-1,550
| -1% | -$40.1K | 0.79% | 30 |
|
2021
Q3 | $3.13M | Sell |
120,810
-3,500
| -3% | -$90.8K | 0.88% | 31 |
|
2021
Q2 | $3.23M | Buy |
124,310
+3,100
| +3% | +$80.4K | 0.91% | 32 |
|
2021
Q1 | $2.89M | Buy |
121,210
+12,350
| +11% | +$294K | 0.97% | 33 |
|
2020
Q4 | $2.11M | Buy |
108,860
+4,350
| +4% | +$84.4K | 0.76% | 32 |
|
2020
Q3 | $1.97M | Buy |
104,510
+22,200
| +27% | +$418K | 0.76% | 30 |
|
2020
Q2 | $1.47M | Sell |
82,310
-1,000
| -1% | -$17.8K | 0.67% | 32 |
|
2020
Q1 | $1.26M | Buy |
83,310
+53,500
| +179% | +$810K | 0.85% | 28 |
|
2019
Q4 | $611K | Buy |
+29,810
| New | +$611K | 0.2% | 62 |
|